Logo

Teva Launches Exclusive First-to-File Generic Version of Cialis in the US

Share this

Teva Launches Exclusive First-to-File Generic Version of Cialis in the US

Shots:

  • Teva launches generic version of Cialis (tadalafil) tablets with dosage (2.5 mg- 5 mg- 10 mg- 20 mg) in the US- with 180 days ANDA exclusivity before the FDA approves other generics
  • Cialis tablets are a phosphodiesterase 5 (PDE5) inhibitor used to treat erectile dysfunction (ED)- benign prostatic hyperplasia (BPH) and with finasteride to initiate BPH treatment for 26 weeks
  • On an average 30M men are affected with ED and 15M have symptomatic BPH in the US. In July- 2018 Lily’s Cialis had an annual sales of ~ $1.9B in the US

Ref: Teva pharmaceuticals | Image: Investinontario

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions